SE9900070D0 - New use - Google Patents

New use

Info

Publication number
SE9900070D0
SE9900070D0 SE9900070A SE9900070A SE9900070D0 SE 9900070 D0 SE9900070 D0 SE 9900070D0 SE 9900070 A SE9900070 A SE 9900070A SE 9900070 A SE9900070 A SE 9900070A SE 9900070 D0 SE9900070 D0 SE 9900070D0
Authority
SE
Sweden
Prior art keywords
new use
melagatran
prodrug
inflammation
medicament
Prior art date
Application number
SE9900070A
Other languages
English (en)
Inventor
Ian Kirk
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9900070A priority Critical patent/SE9900070D0/sv
Publication of SE9900070D0 publication Critical patent/SE9900070D0/sv
Priority to AT00902232T priority patent/ATE319473T1/de
Priority to ES00902232T priority patent/ES2257282T3/es
Priority to CNB008027935A priority patent/CN1170592C/zh
Priority to AU23361/00A priority patent/AU767077B2/en
Priority to DK00902232T priority patent/DK1150704T3/da
Priority to EP00902232A priority patent/EP1150704B1/en
Priority to JP2000593326A priority patent/JP2002534477A/ja
Priority to NZ512713A priority patent/NZ512713A/en
Priority to US09/508,762 priority patent/US6683054B1/en
Priority to PCT/SE2000/000051 priority patent/WO2000041716A1/en
Priority to SI200030848T priority patent/SI1150704T1/sl
Priority to IL14398500A priority patent/IL143985A0/xx
Priority to KR1020017008824A priority patent/KR100701539B1/ko
Priority to CA002356611A priority patent/CA2356611A1/en
Priority to DE60026491T priority patent/DE60026491T2/de
Priority to PT00902232T priority patent/PT1150704E/pt
Priority to BR0007452-7A priority patent/BR0007452A/pt
Priority to ZA200105275A priority patent/ZA200105275B/en
Priority to NO20013414A priority patent/NO20013414D0/no
Priority to US10/685,003 priority patent/US20040082518A1/en
Priority to CY20061100757T priority patent/CY1107465T1/el
Priority to US11/896,035 priority patent/US20080058303A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
SE9900070A 1999-01-13 1999-01-13 New use SE9900070D0 (sv)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE9900070A SE9900070D0 (sv) 1999-01-13 1999-01-13 New use
BR0007452-7A BR0007452A (pt) 1999-01-13 2000-01-13 Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação
PCT/SE2000/000051 WO2000041716A1 (en) 1999-01-13 2000-01-13 New use of melagatran
IL14398500A IL143985A0 (en) 1999-01-13 2000-01-13 New use of melagatran
CNB008027935A CN1170592C (zh) 1999-01-13 2000-01-13 美拉加林的新用途
AU23361/00A AU767077B2 (en) 1999-01-13 2000-01-13 New use of melagatran
DK00902232T DK1150704T3 (da) 1999-01-13 2000-01-13 Melagatran til behandling af betændelse
EP00902232A EP1150704B1 (en) 1999-01-13 2000-01-13 Melagatran for the treatment of inflammation
JP2000593326A JP2002534477A (ja) 1999-01-13 2000-01-13 メラガトランの新規使用
NZ512713A NZ512713A (en) 1999-01-13 2000-01-13 New use of melagatran
US09/508,762 US6683054B1 (en) 1999-01-13 2000-01-13 Use of melagatran
AT00902232T ATE319473T1 (de) 1999-01-13 2000-01-13 Melagatran zur behandlung von entzündungen
SI200030848T SI1150704T1 (sl) 1999-01-13 2000-01-13 Melagatran za zdravljenje vnetja
ES00902232T ES2257282T3 (es) 1999-01-13 2000-01-13 Melagatran para el tratamiento de inflamacion.
KR1020017008824A KR100701539B1 (ko) 1999-01-13 2000-01-13 멜라가트란의 신규 용도
CA002356611A CA2356611A1 (en) 1999-01-13 2000-01-13 New use of melagatran
DE60026491T DE60026491T2 (de) 1999-01-13 2000-01-13 Melagatran zur behandlung von entzündungen
PT00902232T PT1150704E (pt) 1999-01-13 2000-01-13 Melagatran para o tratamento da inflamacao
ZA200105275A ZA200105275B (en) 1999-01-13 2001-06-26 New use of melagatran.
NO20013414A NO20013414D0 (no) 1999-01-13 2001-07-10 Ny anvendelse av melagatran
US10/685,003 US20040082518A1 (en) 1999-01-13 2003-10-15 New use of melagatran
CY20061100757T CY1107465T1 (el) 1999-01-13 2006-06-07 Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
US11/896,035 US20080058303A1 (en) 1999-01-13 2007-08-29 Use of melagatran

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900070A SE9900070D0 (sv) 1999-01-13 1999-01-13 New use

Publications (1)

Publication Number Publication Date
SE9900070D0 true SE9900070D0 (sv) 1999-01-13

Family

ID=20414074

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9900070A SE9900070D0 (sv) 1999-01-13 1999-01-13 New use

Country Status (20)

Country Link
US (3) US6683054B1 (sv)
EP (1) EP1150704B1 (sv)
JP (1) JP2002534477A (sv)
KR (1) KR100701539B1 (sv)
CN (1) CN1170592C (sv)
AT (1) ATE319473T1 (sv)
AU (1) AU767077B2 (sv)
BR (1) BR0007452A (sv)
CA (1) CA2356611A1 (sv)
CY (1) CY1107465T1 (sv)
DE (1) DE60026491T2 (sv)
DK (1) DK1150704T3 (sv)
ES (1) ES2257282T3 (sv)
IL (1) IL143985A0 (sv)
NO (1) NO20013414D0 (sv)
NZ (1) NZ512713A (sv)
PT (1) PT1150704E (sv)
SE (1) SE9900070D0 (sv)
WO (1) WO2000041716A1 (sv)
ZA (1) ZA200105275B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900070D0 (sv) * 1999-01-13 1999-01-13 Astra Ab New use
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
DE10064797A1 (de) * 2000-12-22 2002-06-27 Knoll Ag Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon
SE0101762D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab New use
DE10133786A1 (de) * 2001-07-16 2003-02-06 Boehringer Ingelheim Pharma Verwendung von Thrombin-Inhibitoren zur Behandlung von Arthritis
SE0103590D0 (sv) 2001-10-26 2001-10-26 Astrazeneca Ab New Combination
SE0200198D0 (sv) 2002-01-23 2002-01-23 Astrazeneca Ab New use
SE0203349D0 (sv) * 2002-11-12 2002-11-12 Astrazeneca Ab New use
SG10201502484SA (en) 2010-03-30 2015-05-28 Verseon Corp Multisubstituted aromatic compounds as inhibitors of thrombin
CN105209440B (zh) 2013-03-15 2019-07-23 维颂公司 作为凝血酶抑制剂的卤代吡唑
LT2968297T (lt) 2013-03-15 2019-01-10 Verseon Corporation Multipakeistieji aromatiniai junginiai kaip serino proteazės inhibitoriai
CN106687445A (zh) 2014-09-17 2017-05-17 维颂公司 作为丝氨酸蛋白酶抑制剂的吡唑基取代的吡啶酮化合物
CA2977993A1 (en) 2015-02-27 2016-09-01 Verseon Corporation Substituted pyrazole compounds as serine protease inhibitors
WO2020014669A1 (en) 2018-07-13 2020-01-16 Verseon Corporation Thrombin inhibitors, formulations, and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US6042821A (en) * 1995-11-21 2000-03-28 Smithkline Beecham Corporation Method of treating sepsis with chemokines
AR005245A1 (es) * 1995-12-21 1999-04-28 Astrazeneca Ab Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
SE9600216D0 (sv) * 1996-01-18 1996-01-18 Hans Arne Hansson Styrning av läkningsprocesser
US5669754A (en) * 1996-04-22 1997-09-23 Advanced Dynamics Corporation Ltd. Method and apparatus for collecting plates
SE9601556D0 (sv) 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
SE9603724D0 (sv) * 1996-10-11 1996-10-11 Astra Ab New pharmaceutical parenteral formulation of a thrombin inhibitor
SE9802974D0 (sv) 1998-09-03 1998-09-03 Astra Ab New crystalline forms
WO2000018352A2 (en) 1998-09-28 2000-04-06 Merck & Co., Inc. A method for treating inflammatory diseases by administering a thrombin inhibitor
SE9900070D0 (sv) * 1999-01-13 1999-01-13 Astra Ab New use
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.

Also Published As

Publication number Publication date
DE60026491T2 (de) 2006-11-02
CN1341028A (zh) 2002-03-20
AU767077B2 (en) 2003-10-30
CN1170592C (zh) 2004-10-13
AU2336100A (en) 2000-08-01
ZA200105275B (en) 2002-09-26
NO20013414L (no) 2001-07-10
ATE319473T1 (de) 2006-03-15
EP1150704A1 (en) 2001-11-07
CY1107465T1 (el) 2012-12-19
WO2000041716A1 (en) 2000-07-20
CA2356611A1 (en) 2000-07-20
BR0007452A (pt) 2001-10-16
US20040082518A1 (en) 2004-04-29
ES2257282T3 (es) 2006-08-01
PT1150704E (pt) 2006-06-30
US20080058303A1 (en) 2008-03-06
DE60026491D1 (de) 2006-05-04
NO20013414D0 (no) 2001-07-10
KR100701539B1 (ko) 2007-03-30
KR20010101492A (ko) 2001-11-14
NZ512713A (en) 2004-10-29
EP1150704B1 (en) 2006-03-08
DK1150704T3 (da) 2006-06-12
US6683054B1 (en) 2004-01-27
JP2002534477A (ja) 2002-10-15
IL143985A0 (en) 2002-04-21

Similar Documents

Publication Publication Date Title
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
NO20031019L (no) Vedvarende frigivelsesformuleringer av oksymorfon
JO2282B1 (en) Oxazole derivatives
ATE341550T1 (de) Quinolinyl-pyrrolopyrazole
ATE402176T1 (de) Pyrrolidin- und azetidinverbindungen alsccr5- antagonisten
SE9900961D0 (sv) Novel compounds
SE0101932D0 (sv) Pharmaceutical combinations
GB0002336D0 (en) Medicaments
SE9802208D0 (sv) Novel compounds
PL351710A1 (en) Anti−inflammatory therapy for inflammatory mediated infection
ATE360428T1 (de) Analgetisches arzneimittel
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
IS6130A (is) Bólgueyðandi meðhöndlun fyrir bólgu tengt smit
SE9802209D0 (sv) Novel compounds
NO20032006D0 (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
SE0004827D0 (sv) Therapeutic compounds
SE0300535D0 (sv) Treatment of burns
SE9602262D0 (sv) New use of derivatives of cystine
SE0101762D0 (sv) New use
SE9900438D0 (sv) The pharmacological use of certian cystine derivatives